Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444424) titled 'A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AstraZeneca
Condition:
Healthy Participants
Intervention:
Drug: AZD5004
Drug: Mitiglinide
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March 13, 2026
Target Sample Size: 32
Countries of Recruitment:
Japan
To know more, visit https://clinicaltrials.gov/study/NCT07444424
Publishe...